312 related articles for article (PubMed ID: 17989143)
1. TNF-alpha inhibition reduces renal injury in DOCA-salt hypertensive rats.
Elmarakby AA; Quigley JE; Imig JD; Pollock JS; Pollock DM
Am J Physiol Regul Integr Comp Physiol; 2008 Jan; 294(1):R76-83. PubMed ID: 17989143
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor alpha blockade increases renal Cyp2c23 expression and slows the progression of renal damage in salt-sensitive hypertension.
Elmarakby AA; Quigley JE; Pollock DM; Imig JD
Hypertension; 2006 Mar; 47(3):557-62. PubMed ID: 16415373
[TBL] [Abstract][Full Text] [Related]
3. Heme arginate therapy enhanced adiponectin and atrial natriuretic peptide, but abated endothelin-1 with attenuation of kidney histopathological lesions in mineralocorticoid-induced hypertension.
Ndisang JF; Jadhav A
J Pharmacol Exp Ther; 2010 Jul; 334(1):87-98. PubMed ID: 20392817
[TBL] [Abstract][Full Text] [Related]
4. Aggravated renal inflammatory responses in TRPV1 gene knockout mice subjected to DOCA-salt hypertension.
Wang Y; Wang DH
Am J Physiol Renal Physiol; 2009 Dec; 297(6):F1550-9. PubMed ID: 19794112
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of endothelin B receptors in kidneys of DOCA-salt hypertensive rats.
Pollock DM; Allcock GH; Krishnan A; Dayton BD; Pollock JS
Am J Physiol Renal Physiol; 2000 Feb; 278(2):F279-86. PubMed ID: 10662732
[TBL] [Abstract][Full Text] [Related]
6. Reduced NO production rapidly aggravates renal function through the NF-κB/ET-1/ETA receptor pathway in DOCA-salt-induced hypertensive rats.
Kimura K; Ohkita M; Koyama M; Matsumura Y
Life Sci; 2012 Oct; 91(13-14):644-50. PubMed ID: 22569294
[TBL] [Abstract][Full Text] [Related]
7. Role of the monocyte chemoattractant protein-1/C-C chemokine receptor 2 signaling pathway in transient receptor potential vanilloid type 1 ablation-induced renal injury in salt-sensitive hypertension.
Wang Y; Zhu M; Xu H; Cui L; Liu W; Wang X; Shen S; Wang DH
Exp Biol Med (Maywood); 2015 Sep; 240(9):1223-34. PubMed ID: 25585624
[TBL] [Abstract][Full Text] [Related]
8. Endothelin-1 and CYP450 arachidonate metabolites interact to promote tissue injury in DOCA-salt hypertension.
Oyekan AO; McAward K; Conetta J; Rosenfeld L; McGiff JC
Am J Physiol; 1999 Mar; 276(3):R766-75. PubMed ID: 10070137
[TBL] [Abstract][Full Text] [Related]
9. Triptolide attenuates renal damage by limiting inflammatory responses in DOCA-salt hypertension.
Zhang J; Zhu M; Zhang S; Xie S; Gao Y; Wang Y
Int Immunopharmacol; 2020 Dec; 89(Pt A):107035. PubMed ID: 33045566
[TBL] [Abstract][Full Text] [Related]
10. Obesity induced renal oxidative stress contributes to renal injury in salt-sensitive hypertension.
Quigley JE; Elmarakby AA; Knight SF; Manhiani MM; Stepp DW; Olearzcyk JJ; Imig JD
Clin Exp Pharmacol Physiol; 2009 Jul; 36(7):724-8. PubMed ID: 19207724
[TBL] [Abstract][Full Text] [Related]
11. Effects of alpha-lipoic acid on deoxycorticosterone acetate-salt-induced hypertension in rats.
Takaoka M; Kobayashi Y; Yuba M; Ohkita M; Matsumura Y
Eur J Pharmacol; 2001 Jul; 424(2):121-9. PubMed ID: 11476758
[TBL] [Abstract][Full Text] [Related]
12. Tumor Necrosis Factor Alpha Deficiency Improves Endothelial Function and Cardiovascular Injury in Deoxycorticosterone Acetate/Salt-Hypertensive Mice.
Cai R; Hao Y; Liu YY; Huang L; Yao Y; Zhou MS
Biomed Res Int; 2020; 2020():3921074. PubMed ID: 32190663
[TBL] [Abstract][Full Text] [Related]
13. Omapatrilat increases renal endothelin in deoxycorticosterone acetate-salt hypertensive rats.
Elmarakby AA; Morsing P; Pollock JS; Pollock DM
Vascul Pharmacol; 2003 Dec; 40(5):253-9. PubMed ID: 15259792
[TBL] [Abstract][Full Text] [Related]
14. Heme-arginate suppresses phospholipase C and oxidative stress in the mesenteric arterioles of mineralcorticoid-induced hypertensive rats.
Ndisang JF; Jadhav A
Hypertens Res; 2010 Apr; 33(4):338-47. PubMed ID: 20203687
[TBL] [Abstract][Full Text] [Related]
15. Sodium butyrate ameliorates deoxycorticosterone acetate/salt-induced hypertension and renal damage by inhibiting the MR/SGK1 pathway.
Wu C; Chen Z; Zhang L; Zhu Y; Deng M; Huang C; Liu Y; Zhu Q; Wang L
Hypertens Res; 2021 Feb; 44(2):168-178. PubMed ID: 32908237
[TBL] [Abstract][Full Text] [Related]
16. Grape seed proanthocyanidins prevent DOCA-salt hypertension-induced renal injury and its mechanisms in rats.
Lan CZ; Ding L; Su YL; Guo K; Wang L; Kan HW; Ou YR; Gao S
Food Funct; 2015 Jul; 6(7):2179-86. PubMed ID: 26011796
[TBL] [Abstract][Full Text] [Related]
17. ETA receptor blockade attenuates the hypertension but not renal dysfunction in DOCA-salt rats.
Allcock GH; Venema RC; Pollock DM
Am J Physiol; 1998 Jul; 275(1):R245-52. PubMed ID: 9688985
[TBL] [Abstract][Full Text] [Related]
18. Renal Inflammation in DOCA-Salt Hypertension.
Banek CT; Gauthier MM; Van Helden DA; Fink GD; Osborn JW
Hypertension; 2019 May; 73(5):1079-1086. PubMed ID: 30879356
[TBL] [Abstract][Full Text] [Related]
19. Renoprotective effect of rosuvastatin in DOCA-salt hypertensive rats.
Bae EH; Kim IJ; Park JW; Ma SK; Lee JU; Kim SW
Nephrol Dial Transplant; 2010 Apr; 25(4):1051-9. PubMed ID: 19948880
[TBL] [Abstract][Full Text] [Related]
20. Pentosan polysulfate preserves renal microvascular P2X1 receptor reactivity and autoregulatory behavior in DOCA-salt hypertensive rats.
Guan Z; Singletary ST; Cha H; Van Beusecum JP; Cook AK; Pollock JS; Pollock DM; Inscho EW
Am J Physiol Renal Physiol; 2016 Mar; 310(6):F456-65. PubMed ID: 26697978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
